naproxen has been researched along with kallidin in 1 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (kallidin) | Trials (kallidin) | Recent Studies (post-2010) (kallidin) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 534 | 12 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bova, MP; Butelman, ER; Chavez, RA; Chen, L; Dreyer, M; Fukuda, JY; Garofalo, AW; Hawkinson, JE; Holcomb, R; Hom, DS; Ko, MC; Liao, A; Malmberg, AB; Ruslim, L; Samant, B; Simmonds, S; Szoke, BG; Wadsworth, A; Zeitz, KP; Zhang, H; Zmolek, W | 1 |
1 other study(ies) available for naproxen and kallidin
Article | Year |
---|---|
Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
Topics: Analgesics; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bradykinin; Bradykinin B1 Receptor Antagonists; Calcium; Carrageenan; Cell Line; Cell Membrane Permeability; Fibroblasts; Humans; Hyperalgesia; Kallidin; Macaca mulatta; Mice; Mice, Knockout; Microsomes, Liver; Molecular Structure; Naltrexone; Naproxen; Narcotic Antagonists; Rats; Receptor, Bradykinin B1; Species Specificity; Spiro Compounds; Transfection | 2007 |